Codex DNA Inc reports results for the quarter ended in June - Earnings Summary

Telesis Bio

10/08/2022 01:42

* Codex DNA Inc  DNAY.OQ  reported a quarterly adjusted loss
of 50
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 51 cents per share.
    * Revenue rose 98.3% to $5.66 million from a year ago;
analysts
expected $4.45 million. 
    * Codex DNA Inc's reported EPS for the quarter was a loss
of 50
cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Codex DNA Inc shares had risen by 27.8% this quarter and
lost 78.7% so far this year.
    * The company reported a quarterly loss of $14.83 million.
    * Wall Street's median 12-month price target for Codex DNA
Inc is
$9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 12:42 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.51          -0.50          Beat
 Mar. 31 2022      -0.42          -0.45          Missed
 Dec. 31 2021      -0.37          -0.43          Missed
 Sep. 30 2021      -0.28          -0.34          Missed